A tumor microenvironment-related mRNA–ncRNA signature for prediction early relapse and chemotherapeutic sensitivity in early-stage lung adenocarcinoma
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Cancer Research and Clinical Oncology"
DOI: 10.1007/s00432-021-03718-z
Abstract: Postoperative early relapse of early-stage lung adenocarcinoma is implicated in poor prognosis. The purpose of our study was to develop an integrated mRNA and non-coding RNA (ncRNA) signature to identify patients at high risk of… read more here.
Keywords: lung adenocarcinoma; stage lung; early relapse; signature ... See more keywords
Clinicopathologic predictors of early relapse in advanced epithelial ovarian cancer: development of prediction models using nationwide data.
Sign Up to like & getrecommendations! Published in 2021 at "Cancer epidemiology"
DOI: 10.1016/j.canep.2021.102008
Abstract: OBJECTIVE To identify clinicopathologic factors predictive of early relapse (platinum-free interval (PFI) of ≤6 months) in advanced epithelial ovarian cancer (EOC) in first-line treatment, and to develop and internally validate risk prediction models for early… read more here.
Keywords: cancer; model; prediction models; early relapse ... See more keywords
SUB-SMAS Reconstructıon of Retaınıng Lıgaments.
Sign Up to like & getrecommendations! Published in 2022 at "Aesthetic surgery journal"
DOI: 10.1093/asj/sjac117
Abstract: BACKGROUND Retaining ligaments must be fully released for effective soft tissue mobilization during Sub-SMAS facelifts. Standart deep temporal fascia and lateral SMAS fixation techniques may fail earlier than anticipated, which may cause a relapse of… read more here.
Keywords: retaining ligaments; relapse; reconstruction; sub smas ... See more keywords
P016 Efficiency of evaluating the expression of Toll-like receptors 2, 4, 6 and proteins proteomic profiling as integral indicators for predicting the risk of early relapse of ulcerative colitis
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Crohn's and Colitis"
DOI: 10.1093/ecco-jcc/jjz203.145
Abstract: Success was made in the study of TLR in congenital and adaptive immunity, which determined a new look at immune processes at ulcerative colitis (UC). Modern achievements of proteomic methods of analysis research allow to… read more here.
Keywords: risk; early relapse; colitis; expression ... See more keywords
Extranodal site of diffuse large B‐cell lymphoma and the risk of R‐CHOP chemotherapy resistance and early relapse
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Clinical Practice"
DOI: 10.1111/ijcp.13594
Abstract: About 20%‐30% of diffuse large B‐cell lymphoma (DLBCL) patients experience early disease progression despite R‐CHOP chemotherapy treatment. Revised international prognostic index (R‐IPI) score could risk stratify DLBCL patients but does not identify exactly which patient… read more here.
Keywords: chop chemotherapy; early relapse; large cell; diffuse large ... See more keywords
Venetoclax and DLI for Patients with Early Relapse of Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation. a Historical Prospective Multicenter Trial
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-126999
Abstract: Introduction: Prognosis in patients with post allogeneic HCT-early relapse of AML is dismal and response to salvage treatment is less than 20%. Venetoclax has been shown to be safe and efficacious in frail/elderly patients with… read more here.
Keywords: response; venetoclax dli; early relapse; relapse ... See more keywords
Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk.
Sign Up to like & getrecommendations! Published in 2019 at "Haematologica"
DOI: 10.3324/haematol.2019.236588
Abstract: Multiple Myeloma (MM) management and survival have dramatically improved in the last decade, notably with triple combinations including one immunomodulatory drug (IMiD) and one proteasome inhibitor (PI) for induction treatment, and high dose therapy (HDT)… read more here.
Keywords: risk; myeloma; associated poor; treatment ... See more keywords
Identifying and Validating of an Autophagy-Related Gene Signature for the Prediction of Early Relapse in Breast Cancer
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.824362
Abstract: Background Compelling evidence has demonstrated the pivotal role of autophagy in the prognosis of breast cancer. Breast cancer (BC) patients with early relapse consistently exhibited worse survival. Methods The autophagy-related genes were derived from the… read more here.
Keywords: autophagy related; early relapse; gene signature; signature ... See more keywords
Development and Validation of an Autophagy Score Signature for the Prediction of Post-operative Survival in Colorectal Cancer
Sign Up to like & getrecommendations! Published in 2019 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2019.00878
Abstract: Background: Survival rates for Colorectal cancer (CRC) patients who experienced early relapse have usually been relatively low. Our study aims at developing an autophagy signature that could help to detect early relapse cases in CRC.… read more here.
Keywords: validation; colorectal cancer; early relapse; signature ... See more keywords
A Clinical-Radiomics Nomogram Based on the Apparent Diffusion Coefficient (ADC) for Individualized Prediction of the Risk of Early Relapse in Advanced Sinonasal Squamous Cell Carcinoma: A 2-Year Follow-Up Study
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.870935
Abstract: Purpose To develop and validate a nomogram model combining radiomic features and clinical characteristics to preoperatively predict the risk of early relapse (ER) in advanced sinonasal squamous cell carcinomas (SNSCCs). Methods A total of 152… read more here.
Keywords: relapse advanced; risk early; sinonasal squamous; risk ... See more keywords
Plasma-only circulating tumor DNA analysis detects minimal residual disease and predicts early relapse in hepatocellular carcinoma patients undergoing curative resection
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2023.1119744
Abstract: Background Minimal residual disease (MRD) is considered an essential factor leading to relapse within 2 years (early relapse) after radical surgery, which is challenging to be detected by conventional imaging. Circulating tumor DNA (ctDNA) provides… read more here.
Keywords: ctdna; relapse; mrd; plasma ... See more keywords